Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide injection pens deliver dual-action weight loss therapy through two hormone pathways, and proper setup ensures you receive your full therapeutic dose. Whether you're starting compounded tirzepatide for the first time or switching from another GLP-1 medication, understanding the opening sequence prevents common mistakes and builds confidence in self-administration. PlexusDx serves all 50 states with tirzepatide injections starting at $249 per month from licensed 503A compounding pharmacies.
Gather Your Supplies Before Opening the Tirzepatide Pen
Before you open your tirzepatide injection pen, collect all necessary items on a clean, flat surface. You'll need the pen itself, a sterile needle (typically 29 or 31 gauge for subcutaneous injection), an alcohol prep pad, and a sharps disposal container. Some patients also keep a cotton ball nearby in case of minor bleeding after injection. Having everything ready prevents you from searching for supplies mid-procedure and reduces the risk of contamination.
Check the medication vial or pen exterior for any signs of damage, discoloration, or leakage before opening. Tirzepatide should appear clear and colorless; cloudiness or particles indicate the medication has been compromised and should not be used. Verify the expiration date matches your prescription date, and confirm the dose strength matches your PlexusDx treatment plan. Taking 30 seconds to inspect your medication protects your safety and ensures therapeutic effectiveness.
Remove the Pen Cap and Inspect the Medication
Gently pull the outer pen cap straight off by gripping the ridged edges—do not twist, as this can damage the delivery mechanism. Once the cap is removed, you'll see the medication chamber and the injection button. Set the cap aside on a clean surface if you plan to reuse the pen for future doses; many compounded tirzepatide pens are multi-dose devices. Inspect the medication window to confirm the liquid fills the chamber to the expected level for your prescribed dose.
If your pen has a protective needle shield still attached, remove it by twisting counterclockwise until it separates completely. This shield protects the needle during shipping and storage. Never force or pull the shield straight out, as improper removal can bend the needle or crack the chamber seal. Once removed, the pen is ready for needle attachment and injection preparation.
Attach the Sterile Needle and Prime the Pen
Take your sterile needle and align the threading on the needle base with the threaded port at the tip of the pen. Turn the needle clockwise until it's snug but not over-tightened; excessive force can strip the threads or damage the medication cartridge. Leave the needle shield on for now to maintain sterility. Most compounded tirzepatide pens don't require priming if they've been stored upright, but some healthcare providers recommend dispensing 1–2 units into a sharps container to verify proper flow before injection.
If your PlexusDx dosing instructions specify priming, hold the pen vertically with the needle pointing upward, then press the injection button slowly while pointing the needle into a waste container or sharps bin. You should see a small bead of medication at the needle tip—this confirms the medication pathway is clear and the pen is functioning correctly. Never prime directly on your skin, as this can introduce bacteria or cause unexpected medication loss.
Prepare Your Injection Site and Administer Your Dose
Choose your injection site according to your PlexusDx treatment guidance—most tirzepatide protocols rotate between the abdomen, thigh, or upper arm to reduce lipohypertrophy (thickened tissue from repeated injections). Pinch the skin gently to create a fold, then clean the area with an alcohol prep pad using a circular motion outward from the center. Allow the alcohol to dry for 15–30 seconds; injecting into wet alcohol can sting and reduce medication absorption. Remove the needle shield by twisting counterclockwise and discard it immediately into your sharps container.
Insert the needle at a 90-degree angle through the skin into the subcutaneous fat layer, then press the injection button slowly and steadily until it clicks or stops. Hold the pen in place for 3 seconds after injection to ensure the full dose is delivered, then withdraw the needle at the same angle you inserted it. Immediately place the used needle and pen (if single-use) into your sharps disposal container. Apply light pressure with a cotton ball if needed, but do not rub the injection site, as this can disperse the medication.
Storage, Reuse, and When to Replace Your Tirzepatide Pen
After injection, replace the outer cap on your tirzepatide pen and store it in the refrigerator at 36–46 degrees Fahrenheit (2–8 degrees Celsius) if you're using a multi-dose pen for next week's injection. Some compounded tirzepatide formulations remain stable at room temperature for limited periods—check your medication label or ask your PlexusDx provider about your specific product. Never store tirzepatide in the freezer, and keep it away from direct sunlight or heat sources that can degrade the peptide structure.
Most multi-dose compounded tirzepatide pens last approximately 4 weeks if properly stored and used once weekly. Once your pen is empty or approaching expiration, contact PlexusDx to arrange your next month's supply; tirzepatide injections start at $249 per month with no insurance required and HSA/FSA eligibility. If you notice cloudiness, crystallization, or inability to dispense medication before the scheduled end date, stop using the pen and request a replacement from your pharmacy immediately.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What's the difference between opening a Zepbound pen and a compounded tirzepatide pen from PlexusDx?
Zepbound is an FDA-approved brand version, while PlexusDx tirzepatide comes from licensed 503A compounding pharmacies at $249 per month starting price. The mechanical opening and injection process is nearly identical, but your PlexusDx prescription will include detailed, personalized instructions for your specific formulation. Both delivery mechanisms use subcutaneous injection and similar needle gauges for self-administration.
Can I open my tirzepatide pen before I'm ready to inject?
Yes, you can open the pen cap and prepare it 15–30 minutes before injection, but keep the needle shield on until you're ready to administer the dose to maintain sterility. Do not remove the needle from the pen and reattach it later, as this increases contamination risk. If you need to store an open pen, keep it in the refrigerator and use it within the same day.
What happens if I open the tirzepatide pen incorrectly and damage it?
If you twist the cap instead of pulling straight, or over-tighten the needle, you may crack the medication chamber or misalign the internal mechanism. Contact PlexusDx immediately—your provider can send a replacement pen at no additional charge if the damage occurs during your first use. Always pull the cap straight out rather than rotating it to prevent this issue.
Is opening my tirzepatide pen for the first time nerve-wracking? How can I feel more confident?
Most patients feel nervous opening their first injection pen, which is completely normal. PlexusDx recommends reviewing the step-by-step instructions once before your injection day, then following them slowly and deliberately. Many patients find their second and third injections feel significantly easier once the mechanics become familiar. Your PlexusDx provider is available to answer questions or schedule a phone coaching call before your first dose.
Can the Precision Peptide Genetic Test help predict how well I'll respond to tirzepatide injection?
Yes—PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes genetic variants in the GLP1R, GIPR, FTO, and MC4R pathways that influence tirzepatide response and personalized dosing needs. Understanding your genetic profile helps your provider optimize your tirzepatide protocol and predict which dose range may work best for your body.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Health Journey: What Medications Not to Take with Ozempic
How to Reduce Ozempic Side Effects: Strategies for a Smoother Experience